Addex Financial Statements From 2010 to 2025

Addex Therapeutics Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 4 M 4.2 M 16.8 M Slightly volatile Short and Long Term Debt Total 448 K 396 K 480.6 K Very volatile Other Current Liabilities 1.1 M 1.1 M 1.4 M Pretty Stable Total Current Liabilities 4 M 2.6 M 3.4 M Pretty Stable Total Stockholder Equity 979.4 K 1 M 12.8 M Slightly volatile Property Plant And Equipment Net 301.8 K 317.6 K 819.4 K Slightly volatile Current Deferred Revenue 412.9 K 270.2 K 289.9 K Slightly volatile Accounts Payable 1.3 M 885.9 K 1.5 M Slightly volatile Cash 3.3 M 3.5 M 14.6 M Slightly volatile Non Current Assets Total 348.2 K 366.6 K 1.4 M Slightly volatile Non Currrent Assets Other 46.5 K 48.9 K 532.6 K Slightly volatile Cash And Short Term Investments 3.3 M 3.5 M 14.6 M Slightly volatile Common Stock Total Equity 39.7 M 37.8 M 21.6 M Slightly volatile Common Stock Shares Outstanding 676.5 K 712.1 K 7.3 M Pretty Stable Liabilities And Stockholders Equity 4 M 4.2 M 16.8 M Slightly volatile Other Current Assets 185.5 K 195.3 K 506.2 K Slightly volatile Other Stockholder Equity 285.2 M 379.4 M 273.1 M Slightly volatile Total Liabilities 4.5 M 3.1 M 4 M Very volatile Property Plant And Equipment Gross 2.4 M 4.2 M 2 M Slightly volatile Total Current Assets 3.6 M 3.8 M 15.4 M Slightly volatile Short Term Debt 193.4 K 315 K 144.5 K Slightly volatile Common Stock 2 M 2.1 M 14.2 M Very volatile Non Current Liabilities Total 761.6 K 693.6 K 703 K Pretty Stable Net Receivables 271.7 K 136.1 K 403 K Slightly volatile Other Assets 66 K 48.9 K 146.5 K Slightly volatile Capital Surpluse 297.8 M 329.3 M 277.7 M Slightly volatile Property Plant Equipment 275.1 K 458.5 K 222.7 K Slightly volatile Net Invested Capital 979.4 K 1 M 7.2 M Pretty Stable Net Working Capital 1.1 M 1.2 M 7.6 M Pretty Stable Capital Stock 1.6 M 1.7 M 23.6 M Slightly volatile
Addex Therapeutics Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 261.6 K 275.4 K 663.9 K Slightly volatile Total Revenue 2.7 M 1.5 M 1.9 M Pretty Stable Other Operating Expenses 16.8 M 10.7 M 14.5 M Pretty Stable Research Development 2.3 M 2.5 M 5.3 M Pretty Stable Total Operating Expenses 15.5 M 10.7 M 12.7 M Very volatile Selling General Administrative 4.7 M 6.5 M 5.5 M Pretty Stable Interest Income 65.8 K 57.6 K 99 K Slightly volatile Reconciled Depreciation 268.3 K 351.8 K 152.2 K Slightly volatile
Addex Therapeutics Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Stock Based Compensation 1.2 M 2.1 M 1.2 M Slightly volatile Begin Period Cash Flow 5.9 M 6.3 M 17.5 M Slightly volatile Depreciation 261.6 K 275.4 K 663.9 K Slightly volatile End Period Cash Flow 3.3 M 3.5 M 14.6 M Slightly volatile Issuance Of Capital Stock 2 M 2.1 M 24.2 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 2.32 2.44 214 Slightly volatile PTB Ratio 2.55 2.69 11.6394 Pretty Stable Days Sales Outstanding 37.4 39.37 821 Slightly volatile Book Value Per Share 0.0168 0.0177 1.6311 Slightly volatile Average Payables 1.4 M 1.4 M 1.1 M Slightly volatile Stock Based Compensation To Revenue 3.17 2.98 3.106 Pretty Stable Capex To Depreciation 0.0244 0.0257 0.3529 Very volatile PB Ratio 2.55 2.69 11.6394 Pretty Stable Payables Turnover 3.42 6.34 5.1137 Very volatile Sales General And Administrative To Revenue 4.88 5.14 22.1069 Slightly volatile Average Inventory 0.43 0.45 9.3 K Pretty Stable Research And Ddevelopement To Revenue 4.72 4.96 13.2603 Slightly volatile Capex To Revenue 0.0046 0.0049 0.3453 Slightly volatile Cash Per Share 0.0568 0.0598 1.675 Slightly volatile Days Payables Outstanding 56.63 59.61 2 K Pretty Stable Intangibles To Total Assets 0.0023 0.003 0.0034 Pretty Stable Net Debt To EBITDA 0.29 0.31 2.5829 Very volatile Current Ratio 1.6 1.68 4.3209 Pretty Stable Tangible Book Value Per Share 0.0168 0.0177 1.6279 Slightly volatile Receivables Turnover 7.27 9.6 9.4595 Slightly volatile Shareholders Equity Per Share 0.0168 0.0177 1.6311 Slightly volatile Debt To Equity 0.28 0.27 0.0744 Slightly volatile Capex Per Share 1.0E-4 1.0E-4 0.0127 Slightly volatile Graham Net Net 0.0071 0.0075 1.3754 Slightly volatile Average Receivables 442.1 K 530.6 K 372.8 K Pretty Stable Revenue Per Share 0.0237 0.025 0.1751 Slightly volatile Interest Debt Per Share 0.0054 0.0057 0.0155 Slightly volatile Debt To Assets 0.0701 0.0668 0.0286 Slightly volatile Price Book Value Ratio 2.55 2.69 11.6394 Pretty Stable Days Of Payables Outstanding 56.63 59.61 2 K Pretty Stable Ebt Per Ebit 0.72 0.92 0.9971 Slightly volatile Company Equity Multiplier 3.83 3.65 2.3366 Slightly volatile Total Debt To Capitalization 0.22 0.21 0.0619 Slightly volatile Debt Equity Ratio 0.28 0.27 0.0744 Slightly volatile Quick Ratio 1.6 1.68 4.3183 Pretty Stable Net Income Per E B T 0.81 0.91 0.9901 Slightly volatile Cash Ratio 1.46 1.54 4.0893 Pretty Stable Days Of Sales Outstanding 37.4 39.37 821 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 1.14 1.15 1.0219 Slightly volatile Price To Book Ratio 2.55 2.69 11.6394 Pretty Stable Fixed Asset Turnover 3.91 4.11 56.3805 Very volatile Debt Ratio 0.0701 0.0668 0.0286 Slightly volatile Price Sales Ratio 2.32 2.44 214 Slightly volatile Asset Turnover 0.33 0.31 0.1307 Slightly volatile Price Fair Value 2.55 2.69 11.6394 Pretty Stable
Addex Therapeutics Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 3.7 M 3.9 M 41 M Slightly volatile

Addex Fundamental Market Drivers

Addex Upcoming Events

About Addex Therapeutics Financial Statements

Pair Trading with Addex Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Addex Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Addex Therapeutics will appreciate offsetting losses from the drop in the long position's value.When determining whether Addex Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Addex Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Addex Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Addex Therapeutics Stock:

How To Invest In Addex Details

Is Addex Stock a good investment? Details

What is Addex Therapeutics' Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Technical Analysis Details